Max Healthcare Institute Limited has announced its participation in two significant investor conferences scheduled for February 2026. The company will engage with investors and analysts through presentations at these key industry events.

Conference Schedule

The healthcare provider has outlined its participation in the following conferences:

Regulatory Compliance

This announcement has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was communicated to both the National Stock Exchange of India Limited and BSE Limited on February 7, 2026.

Company Profile Overview

Max Healthcare Institute Limited operates as India's largest hospital chain in terms of market capitalization and second largest in terms of revenue and EBITDA. The company maintains a comprehensive network of healthcare facilities with over 5,200 beds across multiple locations.

Key Operational Highlights

The company's network includes:

• 20 healthcare facilities across North India and Mumbai
• State-of-the-art tertiary and quaternary care hospitals in key metropolitan areas
• Multiple medical centres providing specialized healthcare services
• Homecare and pathology businesses under Max@Home and Max Labs brands

Strategic Focus Areas

Max Healthcare Institute Limited continues to focus on clinical excellence, patient care, and technological advancement. The company's participation in these investor conferences demonstrates its commitment to maintaining transparent communication with stakeholders and the investment community.

The presentations will provide investors with insights into the company's operational performance, strategic initiatives, and future growth plans. These engagements are part of the company's regular investor relations activities aimed at keeping stakeholders informed about business developments and market positioning.

Max Healthcare Institute management has disclosed that the company maintains agreements with insurance companies for annual price revisions, according to statements made during a recent conference call.

Insurance Partnership Agreements

The healthcare provider has established structured agreements with insurance companies that include provisions for annual price revisions. These arrangements indicate a systematic approach to managing pricing for healthcare services in coordination with insurance partners.

Management Communication

During the conference call, company management confirmed the existence of these pricing agreements, highlighting the structured nature of the company's relationships with insurance providers. The agreements appear to provide a framework for regular price adjustments on an annual basis.

Strategic Implications

The presence of annual price revision agreements with insurance companies suggests Max Healthcare has established mechanisms for periodic pricing adjustments. These structured arrangements may provide greater predictability in revenue management and pricing coordination with key insurance partners in the healthcare sector.